Diltiazem hydrochloride 100 MG Injection — RxCUI 1791240
RxNorm drug concept · Semantic clinical drug
RxCUI 1791240
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1791240
Official nameDiltiazem hydrochloride 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)39 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diltiazem: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The pills and capsules you take by mouth are used for high blood pressure and for chronic stable angina, which is chest pain from the heart's workload. Some capsule brands, such as...
- Usually it's taken once a day, and you should swallow it whole. Don't open, chew or crush the capsules. Some products, like DILT-XR, are best taken in the morning on an empty stoma...
- How should I take my extended-release capsule or tablet?
- The most common ones are a stuffy or runny nose, headache, sore throat, constipation, cough, and swelling in the legs or ankles. Most are mild. Call your doctor if you faint, feel...
🕸️ Concept Web — How Diltiazem hydrochloride 100 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Diltiazem hydrochloride 100 MG Injection
RxCUI 1791240 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Diltiazem
3443IN -
Diltiazem hydrochloride
203211PIN
-
Diltiazem
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Diltiazem Injection
1791228SCDF -
Diltiazem hydrochloride Injection
2645898SCDFP -
Diltiazem Injectable Product
1151887SCDG -
Diltiazem hydrochloride Injectable Product
2660505SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Diltiazem Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Diltiazem hydrochloride 100 MG
849867SCDC
-
Diltiazem hydrochloride 100 MG
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Diltiazem hydrochloride 100 MG
SCDC · 849867 -
Diltiazem Injection
SCDF · 1791228 -
Diltiazem hydrochloride Injection
SCDFP · 2645898 -
Diltiazem Injectable Product
SCDG · 1151887 -
Diltiazem hydrochloride Injectable Product
SCDGP · 2660505
📦 FDA Products & Package NDCs
2 products · 3 package NDCs
3 package NDCs map to RxCUI 1791240 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-4350-03 | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) /... | Diltiazem Hydrochloride | Hospira, Inc. | 2005-04-30 |
| 51662-1457-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PA... | DILTIAZEM HCI | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-15 |
| 51662-1457-03 | 10 POUCH in 1 CASE (51662-1457-3) / 1 VIAL, PATENT DELIVERY... | DILTIAZEM HCI | HF Acquisition Co LLC, DBA HealthFirst | 2022-12-11 |
Observed labelers:
HF Acquisition Co LLC, DBA HealthFirst (2) ·
Hospira, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1163 | Inj, diltiazem hcl, 0.5 mg | 3 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.